Mesenchymal Stem Cells With Adjuvant Dexamethasone in Patients With Alzheimer's Disease: A Phase IIa Trial.

Dement Neurocogn Disord · 2025 · PMC12599408 · PMID 41220869

Europe PMC DOI

hedged sentence

0.0550

closest p · 1.1× alpha

0.0550

boldest claim

The sentences

did not reach statistical significancep =0.055so close (0.05 < p ≤ 0.1)

these differences did not reach statistical significance between the two groups ( p =0.055).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.